Skip to content
OpenCapital
Get started

AdvanSix ASIX Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Plant Nutrients35%+2.9%
Chemical Intermediates26%+4.0%
Nylon22%-4.3%
Caprolactam17%-5.6%

By geography

See full
International17%+13.3%

Other financials

Income statement

See full
Revenue$404.2M+7.0%
Gross profit$3.8M-92.9%
Net income-$15.5M-167%
EPS (diluted)-$0.58-167%

Balance sheet

See full
Cash & equivalents$17.6M+111%
Total debt$156.4M+7.4%
Total equity$796.3M+0.2%
Total assets$1.7B+5.2%

Cash flow

See full
Operating cash flow-$15.3M-234%
CapEx$35.9M+5.5%
Free cash flow-$51.3M-127%

Valuation

See full
Market cap$535.14M-14.8%
Enterprise value$673.92M-11.9%
P/E40.6×+33.2×
P/S0.4×-0.1×

Profitability

See full
Gross margin7.4%-5.6pp
Net margin0.9%-4.6pp
FCF margin-1.4%—

Returns & leverage

See full
Return on equity1.7%-9.6pp
Debt / equity0.2×0.0×
Current ratio1.2×0.0×